were back on track with 44.5% growth YoY and 3.4% growth QoQ. - In Q1’19, the Company maintained its leadership position with total market share of 31.1% in Brain and Body Boost (“BBB”) products which

% Administrative expenses (109.5) (15.3) (512.5) (29.3) 368.0% Finance costs (Interest expenses) (68.6) (9.7) (205.5) (11.7) 200.0% Other income 83.8 11.7 83.8 4.8 0.1% Share of profit (loss) from investment in an

45.4% 281.47 45.9% 43.76 18.4% SG&A 97.62 18.7% 120.70 19.7% 23.08 23.6% EBIT 140.09 26.8% 160.77 26.2% 20.68 14.8% Share of Gain in Associates - - 1.94 0.3% 1.94 - Interest Expenses 0.63 0.1% 0.43 0.1

Profit 59.13 44.6% 85.50 47.7% 26.37 44.6% SG&A (20.92) (15.8%) (28.47) (15.9%) (7.55) 36.1% EBIT 38.21 28.8% 57.03 31.8% 18.82 49.3% Share of Gain (Loss) in Associates (0.40) (0.3%) 0.43 0.2% 0.83 (207.5

16.1% YoY, driven by C-Vitt, a strong No. 1 brand in the category, whose market share successfully booked a new record high of 31.3% (+580 bps YoY). Osotspa anticipated a stronger C-Vitt growth in 2H’20

% 1,856 -80% 1,112 4,009 -72% Basic earnings per share (Baht) 0.27 0.38 1.35 0.81 2.91 Note: 1/ EBITDA from Refinery Business of the Company, BCP Trading Pte. Ltd. and share of profit from associated

insurance for employees. (2) Expenses for selling securities increased by THB 3.53 million due to the company selling IPO shares during January 2024, thus incurring expenses such as advertising media costs

540 -36% EBITDA Margin (%) 9.0% 7.3% 4.7% -4.3% -2.6% 9.2% 5.9% -3.2% Net Profit 322 145 71 -78% -51% 591 216 -63% EPS (Baht/Share) (1) 0.44 0.20 0.07 -84% -65% 0.80 0.21 -74% Adjusted EBITDA(2) 323 345

, 2024, at a rate of THB 0.15 per share for 620,000,000 shares, resulting in a total dividend payment of THB 93 million. During the period from 2024 to September 30, 2024, the company redeemed

investors. However, the underwriter is required to purchase those shares at a later date, resulting in higher demand when share price is below initial public offering price. In contrary, higher number of